Genetic Association Analysis of Anti-VEGF Treatment Response in Neovascular Age-Related Macular Degeneration

Anti-VEGF treatment for neovascular age-related macular degeneration (nAMD) has been FDA-approved in 2004, and since then has helped tens of thousands of patients worldwide to preserve vision. Still, treatment responses vary widely, emphasizing the need for genetic biomarkers to robustly separate re...

Descripción completa

Detalles Bibliográficos
Autores principales: Strunz, Tobias, Pöllmann, Michael, Gamulescu, Maria-Andreea, Tamm, Svenja, Weber, Bernhard H. F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181567/
https://www.ncbi.nlm.nih.gov/pubmed/35682771
http://dx.doi.org/10.3390/ijms23116094

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181567/
https://www.ncbi.nlm.nih.gov/pubmed/35682771
http://dx.doi.org/10.3390/ijms23116094

Ejemplares similares